Drawing for COVID 19 SENTINEL

USPTO serial 79301184

COVID 19 SENTINEL

Reviewed by CopyMark Law Group

Reg. 6624276Status 700Registered
Filing date
Status date
Registration date
Jan 25, 2022
Examiner
FRENCH, CURTIS W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COVID 19 SENTINEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, and biochemistry; industrial research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; scientific research and development in the fields of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses, clinical and in-vitro studies in the feed, agro, chemical, cosmetic, personal care, agrochemical, biotechnology, aero-space, automobile, consumer products, semiconductor, electronics, energy, magnetic storage and any science-oriented industries and in environmental testing; carrying out scientific study and research in the fields of genetic analyses in the fields of plant and animal products; carrying out scientific study and research in the fields of genetic analyses in the feed, agro, chemical, cosmetic, personal care, biotechnology and consumer products industries; development of methods, namely, establishment and carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; scientific research, medical research and industrial engineering research resulting in expert reports for scientists and engineers; professional consultancy in the fields of scientific and medical research and research on medical treatments; DNA, RNA and virus analyses for scientific purposes; technical project studies; gene libraries, namely, collections of DNA and RNA fragments, variants or combination of genes for medical or veterinary use; scientific and technological services, namely, scientific research, scientific analysis, scientific research consulting, industrial design, engineering, scientific development and genetic laboratory testing services for research purposes for others in the field of genetics and epidemiology; scientific research featuring on-line data collection and provision, data interpretation, consultancy and advisory services related to feed testing services; database design and development; providing online information about industrial analysis and research services in the fields of environmental testing, genetics and epidemiology; providing scientific research information including scientific analysis data and results from an online searchable database; information technology services, namely, providing an online searchable database with algorithms in the field of scientific research analysis results based on genomics data; providing online information in the field of technological research relating to environmental testing, genetics and epidemiology from a computer database or the internet; new product development and research in the fields of biotech products, chemicals and agro-chemicals; scientific research services in the areas of genomics, proteomics, chemistry, biology, epidemiology medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; providing scientific information in the field of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data by using information technology tools and techniques; conducting clinical trials for others in the fields of cosmetics and personal care products; scientific research featuring the use of information technology tools and techniques to work with existing biological data and to generate information on the epidemiology, genomics and proteomics of living organs including human beings through research and study; scientific and technological services, namely, scientific and medical laboratory services, laboratory research and development in the fields of epidemiology, biomedicine and biobanking; consultation and analysis services for scientific research purposes in the fields of biotechnology, medical diagnostics and drug therapy; DNA and RNA analyses for scientific purposes; DNA and RNA screening for scientific purposes; viral screening for scientific purposesACTIVE
044Medical testing services, namely, blood testing, saliva, urine, tissue, hair and body fluid testing services for diagnostic or treatment purposes; serological and urinary testing services for medical, epidemiological purposes; medical testing services in the field of epidemiology and genetics; DNA and RNA analyses for medical testing; DNA and RNA screening for medical testing purposes; viral screening for medical testing purposes; medical and health assessment services in connection with DNA and RNA; genetic testing for medical purposes; hospital services; medical assistance services and medical services in the field of epidemiology and genetics; medical clinic services; medical consultation services; medical consultation in the fields of genetics and epidemiology; maintaining patient medical record online; collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids for medical purposes; medical testing for diagnostic and epidemiological treatment purposes; medical testing for epidemiological diagnosis purposes; medical testing for diagnostic purposes in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of test panels in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of medical biology test panels and the interpretation of medical biology test results; providing bio-pathological medical information and advice relating to medical biology tests; medical testing for diagnostic and treatment purposes featuring testing for assessing immunogenicity, hypersensitivity and adverse immune stimulation; medical testing for diagnostic or treatment purposes in the field of infectious diseases; prenatal diagnostic testing for medical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB
Jul 5, 2022XXCRGENERIC MADRID TRANSACTION CREATED
Apr 25, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 25, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2021RFNTREFUSAL PROCESSED BY IB
Mar 17, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 12, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2021DOCKASSIGNED TO EXAMINER
Mar 2, 2021DOCKASSIGNED TO EXAMINER
Feb 25, 2021DOCKASSIGNED TO EXAMINER
Jan 8, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance